Viewing Study NCT03683251


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-03-15 @ 4:39 AM
Study NCT ID: NCT03683251
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2018-09-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study for the Port Delivery System With Ranibizumab (Portal)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module